ProSciento announced the appointment of Dr. Kelvin Logan, former President of Europe, Asia and Latin America at INC Research, to its Board of Directors.
“Kelvin is a highly accomplished leader in the global clinical R&D industry, and we are very pleased to have an individual of his business and leadership acumen join our Board of Directors,” Dr. Marcus Hompesch, ProSciento’s CEO and Chairman of the Board said. “With his extensive experience and track record in driving strategic growth in the CRO industry, he will bring valuable insight to ProSciento’s Board as we continue our expansion into new geographies and additional capabilities.”
